EMA publishes agenda for 12-15 October CHMP meeting

EMA

12 October 2020 - The EMA has published a draft agenda for this week's CHMP meeting.

The CHMP is due to issue opinions for the following technologies:

  • Budesonide with glycopyrronium and eformoterol fumarate dihydrate
  • Fenfluramine hydrochloride
  • T-cells (autologous)
  • Lenalidomide
  • Inclisiran
  • T-cells, CD34 positive (autologous)
  • Lumasiran
  • Peanut allergen extract
  • Rilpivirine
  • Ivosidenib
  • Cabotegravir

Read CHMP agenda


Michael Wonder

Posted by:

Michael Wonder